Term
Incidence and Trends of Cancer |
|
Definition
Cancer is the second leading cause of death, ♥ dis is 1st
#1 ca in males = prostate= 25% of new cases
#1 ca in females= breast= 25% of new cases
#2 ca = lung/bronchus
#3 = colon/rectal
5yr survival rate is 66% (1996-2003) |
|
|
Term
Cancer Trends
5 yr survival rate |
|
Definition
5 yr survival rate from date of dx/66%= those pts who are
disease free
in remission (leukemia, lymphoma, breast ca)
under treatment
**% does not include pts who are "cured of cancer" |
|
|
Term
|
Definition
Leukemia
Neuroblastoma (brain)
Wilm's Tumor (kidney) |
|
|
Term
Survival Rates in Children
|
|
Definition
5 yr survival rate <1970 = <50%
5 yr survuval rate 1996-2003 = 80%
Survival rates is dependent on type of ca
Late effects are common = organ malfunction, 2dary ca, cognitive impairments |
|
|
Term
|
Definition
Cancer is the transformation of a normal cell to an UNREGULATED cell
(defective mitosis in parts of cell cycle, combination therapy is used to achieve an ↑ chance of survival) |
|
|
Term
|
Definition
Normal cells (of the kidneys, lungs, etc.) have specific functions and an orderly process of progressing from immaturity to maturity.
The daughter cells resemble the mother cells and are differentiated from other cells |
|
|
Term
|
Definition
Two major dsyfunctions present in the process of cancer development
1 defective cell proliferation (growth)= cells divide abnormally & DNA is substituted or permenantly deranged
2 defective cell differentiation = process is interuppted & cells remains immature |
|
|
Term
2 Genes affect Cell Development |
|
Definition
Proto-onco gene = important regulator of cellular progress promoting cell growth
Tumor Suppressor gene = suppresses growth & makes mutations occur in gene |
|
|
Term
3 Properties of Normal Cell Proliferation |
|
Definition
1. Adhesion = cells stick together
2. Contact Inhibition = still prolierate - not inhibited by adhesion
3. Apoptosis = cell death/ divide & die |
|
|
Term
Defects in Cellular Proliferation
|
|
Definition
1. Loss of Adhesion (where body system allows metastisis /lymph & bone marrow)=allows cells to break off from main tumor and move thru bld vesl & tissue (mets)
2. Loss of Contact Inhibition=cells grow on top of each other and on top & between norml cells
3. Loss of apoptosis = ca cells respond diferently than normal cells to intracellular signals regulating equilibrium, divide indicriminately, & are immortal |
|
|
Term
|
Definition
Proto- Onco Genes = regulate nml cell process & promote growth
Tumor Suppressor Genes = suppress growth |
|
|
Term
Defect in Differentiation
|
|
Definition
lose appearance and function of parent cell
Proto-onco genes to oncogenes
Tumor suppressor genes are rendered inactive |
|
|
Term
|
Definition
Benign Neoplasm
Malignant Neoplasm
Neoplasm = new growth |
|
|
Term
Characteristics of Benign Neoplasms |
|
Definition
well differentiated
Encapsulated (usually)
expansive mode of growth
similar to parent cell
metastisis is absent
rarely recur |
|
|
Term
Characteristics of Malignant Neoplasms |
|
Definition
ranges from well differentiated to undifferentiated
able to metastisize
infiltrative & expansive growth
frequent reoccurrence
moderate to marked vascularity
rarely encapsulated (allowing them to metastisize more quickly)
becomes less like the parent cell |
|
|
Term
3 stages of the Development of Cancer |
|
Definition
1. Initiation of Cells
2. Promotion = (aboout 1/2 deaths in US related to ) Tobacco, inactivity, obesity, poor diet
3. Progression |
|
|
Term
|
Definition
Immune system rejects or destroys cancer cell (may be inadequate as ca cells arise from normal human cells)
Some ca cells have changes on their surface antigens =TAA=tumor assoc'd antigens
TAA= responsible for the development of tumors |
|
|
Term
|
Definition
Genetic (ex: colon, breast)
Chemical
Environmental
Viral (infectious mono)
Immunologic |
|
|
Term
Tumor Markers Role in Cancer |
|
Definition
Tumor Markers:
Confirm Diagnosis
Assess Response to Therapy
Predict Prognosis (high levels of tumor markers = high mortality rate) |
|
|
Term
|
Definition
Ca-125 = ovarian cancer
Ca-19-9= pancreatic & gallbladder cancer
PSA (prostate specific antigen) = prostate cancer
AFP (alpha fetoprotein) = malignant liver cells
CEA (carcinoembryonic antigen) = cancers of the GI tract |
|
|
Term
Routine Screening Tests for Cancer |
|
Definition
Breast Exam = clinical (CBE) 1xyr self (SBE) monthly/7d prior to cycle
Mammography @ 40yrs and after
MRI
PAP
HPV 26yrs & under
PSA
FOBT/FIT (fecal occult blood test / fecal immunochemical test)
Double contrast Barium Enema, Sigmoidoscopy, Colonoscopy, DRE |
|
|
Term
Diagnositic Tests for Cancer |
|
Definition
Biopsy= definitive means to diagnosis
Needle (aspirate contents from tumor)
Incisional (incision to bx a piece of tissue)
Excisional (removal of tumor itself)
Imaging
Blood Studies=CBC shows immature cells (differential, enzymes, bilirubin, LFT)
Bone Marrow aspiration - leukemia, lymphoma , done in hip or sternum
Oscopies |
|
|
Term
Histological Classification of Cancer |
|
Definition
classification defines by the :
appearance of cells and the degree of differentiation
**poorly differentiated tumors have worse prognosis than those who are closer in appearance to normal cells |
|
|
Term
Four grades of Abnormal Cells by Histological Classification |
|
Definition
grade 1 = cells differ slightly from nml cells and are well differentiated
grade 2 = cells more abnormal and moderately differentiated
grade 3 = cells very abnormal and poorly differentiated
grade 4 = cells immature, primitive and undifferentiated/the cell of origin is difficult to determine |
|
|
Term
Anatomical Classification of Cancer / Clinical Staging
|
|
Definition
Stage 0 = cancer in situ
stage 1 = tumor limited to tissue of origin; localized tumor growth
stage 2 = limited local spread
stage 3 = extensive local and regional spread
stage 4 = metastisis |
|
|
Term
TNM Classification of Cancer |
|
Definition
TNM classification represents the anatomic extent of the cancer and is based on three parameters.
T = tumor size and invasiveness
N = spread to lymph node
M = metastisis |
|
|
Term
Goals of the Collaborative Care of Cancer |
|
Definition
Cure = total tumor kill or irradication
Control = Slowing or Arresting growth w/o cure
Palliation = Relieve symptoms, pain, bleeding & obstructions/when cure & control not obtainable, help w/ psychological well being, hospice |
|
|
Term
|
Definition
Surgery = can be used for cure, control a/o palliation, #1 tx, oldest form and primary tx for solid tumors/ eveidence of micrometastasis in 70% of all tumors/sx complemented by radiation, chemotherapy, & biological tx
Radiation Therapy = may be done prior to sx to decrease chance of micrometastasis tumors
Chemotherapy
Biological and Targeted Therapies |
|
|
Term
Role of Surgery in Cancer |
|
Definition
diagnosis/biopsy
determine diagnositic and tx plan/clinical staging
cure a/o control, removal of local ca tissue (primary or met site)
supportive care / prophylactic (masectomy, colon polyp removal)
rehabilitation reconstructive therapy
palliation of symptoms
|
|
|
Term
Considerations for Removal of Cancerous Tumors |
|
Definition
Is tumor made of solid tissue/slow growing & confined to a specific area?
Can a small area of surrounding tissue (nml) be removed w/o causing loss of function or physical limitation?
What is the individuals pre-surgical function?
|
|
|
Term
Consideration before Sx to remove cancerous tumor |
|
Definition
ability to safely remove surrounding malignant tissue to decrease risk of tumor recurrence or spread
obtaining detailed informed consent including potential for physical dysfunction or impairment (physician responsibility)
prioritizing patient wishes |
|
|
Term
HSCT ( Hematopoietic Stem Cell Transplantation) |
|
Definition
Bone Marrow Transplant (BMT) = performed in OR, can be done w/ most ca, extensive radiation prior to BMT to get rid of CA cells, possibly chemo as well
Peripheral stem cell transplantation (PSCT) or (PBSCT) |
|
|
Term
HSCT categories and sources |
|
Definition
Categories:
Allogeneic (different species)
Syngeneic (same species)
Autologous (self)
Sources:
Bone Marrow
Peripheral Blood
Umbilical Cord Blood (insuff #stem cells for adults/good for children) |
|
|
Term
HSCT methods of harvesting stem cells |
|
Definition
1. Bone Marrow
2. Peripheral Blood
3. Umbilical Cord (can be stored and used later) |
|
|
Term
|
Definition
is performed if ca is resistant to chem & radiation tx (non hodgkins & hodgkins, immune deficiency syndrome, acute myologous syndrome, stage 4 neuroblastomas, chronic aplastic anemia
BMT is standard protocol w/ children w/ ALL after first remission |
|
|
Term
|
Definition
Complications include:
bacterial, viral, and fungal infections:
prophylactic abx tx/ pt can become septic , can occur 20-100 days after transplant or histocompatibility or triggered by CMV, epstein barr
Graft-versus- host disease:
T lymphocytes from donor stem cells recognize recipient as foreign
attcks organs such as skin, liver, and GI tract
reduce chance to develop graft vs host by using stem cells from cord blood |
|
|
Term
Role and Uses of Radiation Therapy |
|
Definition
Uses: Curative, Control, Adjunctive, Palliative
High-Energy Ionizing radiation to kill: breaks DNA, rapid division, nml cells
Delivered: externally or Internally (cervical, oral, & prostate ca)
|
|
|
Term
Care of Pt w/ Internal Radiation Therapy |
|
Definition
Radiation Care =
Time = limit time around patient to 30 minutes
Distance = Remain 12-18 inches away from radiation site
Shielding = lead apron if working w/ radiation, wear badges to calculate amount of radiation exposed to / No care to pt if you are pregnant/ pt should be in private room |
|
|
Term
External vs Internal Radiation Therapy |
|
Definition
External = pt is NOT radioactive
Internal = pt IS radioactive |
|
|
Term
Radiation Therapy - Internal (Brachytherapy) |
|
Definition
implantation or insertion of radioactive materials into or close to tumor
minimal exposure to healthy tissue
used in combination w/ teletherapy (external beam radiation)
pt is emitting radioactivity |
|
|
Term
Care of Desquamation from Radiation Therapy |
|
Definition
Dry Desqamation= do not apply anything to skin, can wash & dry only/do not wash off radiation markings
Wet Desquamation = deep underlying tissue burns |
|
|
Term
|
Definition
Chemotherapy = different chemo agents work at diff phases of the cell cycle and are classified as cell specific cycle chemo (G1 & G2)& cell non-specific chemo (all phases of repro cycle)
drugs are given in combination (better chance of arresting ca)
dosages are calculated to BSA
selection of drugs w/ diff modes of action minimizes occurrences and severity of adverse side effects (does & kill more ca cells @ diff phases of cell cycle) |
|
|
Term
|
Definition
the decreaseof all blood cells (in bone marrow) |
|
|
Term
|
Definition
Neutropenia= <2000 WBC
pt needs:
reverse isolation/private room
limit visitors
no children visitors
no fresh fruit or vegetables
no pepper
no fresh flowers or plants
mask for care
Neupogen to help increase WBC |
|
|
Term
|
Definition
|
|
Term
|
Definition
The lowest point of # WBC, RBC, Platelets and is reached w/in 7-10 days of IV chemo |
|
|
Term
Side Effects of Chemo & Radiation Therapies |
|
Definition
Respiratory System: Pneumonitis, Pulmonary Edema, pleural effusion
Cardiovascular: Pericarditis, Cardiotoxicity (drug Andriamycin causes ♥ problems, cardiomyopathy
Psychoemotional: Fatigue, Anxiety
Hematologic System: Anemia, Leukopenia, thrombocytopenia
Genitourinary Tract: Hemorrhagic Cystitis, Reproduction Dsyfunction
Nephrotoxicity |
|
|
Term
Monoclonal Antibodies (MoAb)
Inhibitors |
|
Definition
Rituxan (rituximab) s/e rigors/ inpt only/ binds B cell / non hodgkins lymphoma
Herceptin (Trastuzumab) breast ca / binds Her2+
Avastin (Bevacizumab) colorectal ca / prevents vascularization of tumor |
|
|
Term
Nutrition Problems for the Cancer Patient undergoing treatment |
|
Definition
Cachexia: breakdown of tissue, ↓ albumin, ↓ wgt
Anorexia: ↓ appetite
Xerostomia: ↓ dry mouth
Provide good mouth care, cold foods, smooth foods, little or no chewing is better, more frequent small meals. popsicles |
|
|
Term
Biological Response Modifiers |
|
Definition
agent or approach that modifies the relationship between the tumor and host by modifying the host's biologic response to tumor cells with a resultant therapeutic effect |
|
|
Term
Biologic Response Modifier Therapies |
|
Definition
Immonotherapy: Boost immune system/major focus is MODULATION of the immune sys
Biotherapy/Biological Therapy: agents used are capable of multiple actions No PO/Proteins
Targeted Therapy: agents that interfere w/ specific molecules involved in carcinogenesis & tumor growth/ kill tumor cells w/o damaging healthy cells No PO/proteins /IM |
|
|
Term
Hematopoietic Growth Factors |
|
Definition
Epogen = RBC
Procrit = RBC
Aranesp = RBC
Neupogen = WBC
Neulasta = WBC
Neumega = Platelets |
|
|
Term
Blood Transfusions (for any blood product)
1 of 2 |
|
Definition
******check chart for order & consent***************************
IV access must be 18 or 20 gauge or larger
VS - TPR & BP
Hang blood asap (should be transfused w/in 4hr of recvg from blood bank)
Unsafe to put in refrigerator
ID Check w/ 2 RN's or RN & Doc
Use Y Tubing
NSS only***NO Dextrose
no other meds via line
transfuse slowly. stay 1st 15 minutes
lasix may be ordered to follow infusion
hem <9 = transfusion, if ren failure hem ++lower for transfusion
|
|
|
Term
|
Definition
Assess for Reactions =
***febrile (fever, chills, h/a)response to foreign prot/Tylenol most often given/continue w/ transfusion
***hemolytic (fever, chills, h/a, flushed face, low back pain)/can cause renal failure, STOP transfusion, take down blood, send to blood bank & send blood & urine specime to lab
*** Allergic (hives, itching, anaphylaxsis) STOP transfusion |
|
|
Term
|
Definition
Tyrosine Kinase Inhibitors
Tarceva (Erlotinib)
Gleevec (Imatinib) = transduction & angiogenesis inhibitors |
|
|
Term
|
Definition
Flu like symptoms
liver toxicity
capillary leaks syndrome w/ difficulty breathing
anorexia
infusion reactions (caused by injections) infiltrates=necrosis=stop IV no Flush no Remove
SKIN RASH
HTN
Skin fissures (paronychia)
diarrhea
neurotoxicity, lethary, & atigue
mouth ulcers |
|
|
Term
Blood Transfusions 3 of 3
|
|
Definition
Prep = to help avoid severe reaction> Tylenol, Benadryl, & Prednisone
Reaction to Transfusion > STOP transulsion STAT>KVO w/ NSS> call dr>treat symptoms per protocol
No Reactions > ^ rate after 15min>infuse 4hr or less, ck VS per protocol, monitor for other reactions: fluid volume excess > when transfusion complete flush line w/ NSS |
|
|
Term
|
Definition
Pain is what the patient says it is!
Causes :
Cancer (bone invasion, nerve compression, & GI obstruction)
Treatments:(surgery, diagnostic tests, chemo & radiation) |
|
|
Term
|
Definition
Goals: relief from pain, comfort & quality of life
Measures:
Pharmacologic (analgesics, opioid, non-opioid)(adjuvants)
Non-pharmacologic (comfort measures, surgery, radiation) |
|
|
Term
Analgesics the mainstay of pain management |
|
Definition
Acute Pain (break the pain cycle)
Chronic Pain (begin with non-narcotics)(use adjuvants)
Routes (PO, SQ, IM, IV, topical)
Schedule ATC = best pain control method
PRN = for breakthrough pain |
|
|
Term
|
Definition
Narcotics: MC Contin, Fentanyl patch, Morphine infusion (hospice phase - titrate morphine to relieve them of pain), Dilaudid
Other techniques: PCA Pump, Epidural Infusion, TENS
Pediatric = frequently undermedicated, assess carefully
Elderly = more susceptible to s/e, drug interactions |
|
|
Term
Nurse's Role in Pain Management |
|
Definition
Assess pain and communicate with other health care providers
Ensure initiation of adequate pain relief measures
Evaluate effectiveness of interventions *reassess to see if pain med working
Advocate for those in pain |
|
|
Term
Management of Cancer Pain |
|
Definition
Patient report should always be believed and accepted as primary source for pain assessment data
Drug therapy should be used to control pain
Fear of addiction is unwarranted
Non-pharmacologic interventions including relaxation therapy and imagery can be effectively used |
|
|
Term
|
Definition
Leakage of fluid into tissues rather than into vein |
|
|
Term
|
Definition
Kidney cells do not look like liver cells |
|
|
Term
|
Definition
The use of ionizing radiation from an external source such as linear accelerator |
|
|
Term
|
Definition
Increase in the number of normal cells in a tissue or organ |
|
|
Term
|
Definition
Complete circle of replication |
|
|
Term
|
Definition
Tumor that is generally well differentiated, slow growing, encapsulated and does not metastasize |
|
|
Term
|
Definition
Use of high energy radioactive materials placed into or directly on the body to treat disease |
|
|
Term
|
Definition
The time for the tumor mass to double in size |
|
|
Term
BRM
Biological Response Modifier |
|
Definition
Substances that stimulate and boost the patient's own immunologic response |
|
|
Term
|
Definition
The lowest point immunosuppression of RBC's and WBC's |
|
|
Term
|
Definition
Cancerous Cells are no longer localized |
|
|
Term
|
Definition
Potential life-threatening transfusion reaction |
|
|
Term
|
Definition
A substance that can cause changes in the structure and function of cell that can lead to cancer |
|
|
Term
|
Definition
acheived through high dose chemotherapy and/or radiation prior to bone marrow transplant |
|
|
Term
|
Definition
Energy that is transmitted in the form of waves or particles; used a treatment for cancer |
|
|
Term
|
Definition
Chemotherapy agent that can cause tissue necrosis and sloughling if infiltration occurs |
|
|
Term
|
Definition
Used to confirm a diagnosis, asses a response to therapy, predict or confirm relapse and assess prognosis |
|
|
Term
|
Definition
An alteration in size, shape and organization of cells; strongly associated with neoplastic changes |
|
|
Term
|
Definition
Poorly differentiated cells that grow rapidly, invade adjacent tissue and typically metastasize |
|
|